These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19119442)

  • 1. Weekly low-dose docetaxel for salvage chemotherapy in pretreated elderly or poor performance status patients with non-small cell lung cancer.
    Lee KW; Lim JH; Kim JH; Lee CT; Lee JS
    J Korean Med Sci; 2008 Dec; 23(6):992-8. PubMed ID: 19119442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer.
    Lilenbaum R; Rubin M; Samuel J; Boros L; Chidiac T; Seigel L; Dowlati A; Graham P; Beaumont J; Du H
    J Thorac Oncol; 2007 Apr; 2(4):306-11. PubMed ID: 17409802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.
    Nelli F; Naso G; De Pasquale Ceratti A; Saltarelli R; Dauria G; Lugini A; Ferraldeschi R; Picone V; Moscetti L; Cortesi E
    J Chemother; 2004 Aug; 16(4):392-9. PubMed ID: 15332716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).
    Gervais R; Ducolone A; Breton JL; Braun D; Lebeau B; Vaylet F; Debieuvre D; Pujol JL; Tredaniel J; Clouet P; Quoix E
    Ann Oncol; 2005 Jan; 16(1):90-6. PubMed ID: 15598944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.
    Hainsworth JD; Erland JB; Barton JH; Thompson DS; Stagg MP; Bradof JE; Twele TW; Greco EA;
    Clin Lung Cancer; 2003 Jul; 5(1):33-8. PubMed ID: 14596701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
    Califano R; Griffiths R; Lorigan P; Ashcroft L; Taylor P; Burt P; Lee L; Chittalia A; Harris M; Faivre-Finn C; Thatcher N; Blackhall F
    Lung Cancer; 2011 Sep; 73(3):338-44. PubMed ID: 21296449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer.
    Tibaldi C; Bernardini I; Chella A; Russo F; Vasile E; Malventi M; Falcone A
    Clin Lung Cancer; 2006 May; 7(6):401-5. PubMed ID: 16800966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
    Yoshimura N; Kudoh S; Kimura T; Mitsuoka S; Kyoh S; Tochino Y; Asai K; Kodama T; Ichimaru Y; Yana T; Hirata K
    J Thorac Oncol; 2009 Mar; 4(3):371-5. PubMed ID: 19155998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    Bria E; Cuppone F; Ciccarese M; Nisticò C; Facciolo F; Milella M; Izzo F; Terzoli E; Cognetti F; Giannarelli D
    Cancer Treat Rev; 2006 Dec; 32(8):583-7. PubMed ID: 16919884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
    Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
    J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial.
    Hainsworth JD; Burris HA; Litchy S; Morrissey LH; Barton JH; Bradof JE; Greco FA
    Cancer; 2000 Jul; 89(2):328-33. PubMed ID: 10918162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel monotherapy as second-line treatment for pretreated advanced non-small cell lung cancer patients.
    Ko YH; Lee MA; Hong YS; Lee KS; Park HJ; Yoo IeR; Kim YS; Kim YK; Jo KH; Wang YP; Lee KY; Kang JH
    Korean J Intern Med; 2007 Sep; 22(3):178-85. PubMed ID: 17939335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
    Vázquez S; Grande C; Amenedo M; Fírvida JL; Lázaro M; Alonso G; Curiel T; Huidobro G; Mel JR; Ramos M
    Anticancer Drugs; 2004 Jun; 15(5):489-94. PubMed ID: 15166623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.
    Ohe Y; Niho S; Kakinuma R; Kubota K; Ohmatsu H; Goto K; Nokihara H; Kunitoh H; Saijo N; Aono H; Watanabe K; Tango M; Yokoyama A; Nishiwaki Y
    Ann Oncol; 2004 Jan; 15(1):45-50. PubMed ID: 14679118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.
    Niho S; Ohe Y; Kakinuma R; Kubota K; Matsumoto T; Ohmatsu H; Goto K; Nishiwaki Y
    Lung Cancer; 2002 Feb; 35(2):209-14. PubMed ID: 11804695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer.
    Ishimoto O; Sugawara S; Inoue A; Ishida T; Munakata M; Koinumaru S; Hasegawa Y; Suzuki T; Miki H; Saijo Y; Nukiwa T
    J Thorac Oncol; 2006 Nov; 1(9):979-83. PubMed ID: 17409982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.
    Chen YM; Shih JF; Perng RP; Tsai CM; Whang-Peng J
    Chest; 2006 Apr; 129(4):1031-8. PubMed ID: 16608954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly short infusion of taxotere at a 4 week cycle in Chinese patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based non-taxane chemotherapy--a Phase II trial.
    Tsao TC; Chen CH; Chang JW; Lee CH
    Jpn J Clin Oncol; 2006 Feb; 36(2):80-4. PubMed ID: 16455677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
    Esteban E; González de Sande L; Fernández Y; Corral N; Fra J; Muñiz I; Vieitez JM; Palacio I; Fernández JL; Estrada E; Lacave AJ;
    Ann Oncol; 2003 Nov; 14(11):1640-7. PubMed ID: 14581272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.